Nexviazyme® (avalglucosidase alfa-ngpt)
| Full Name | Nexviazyme® (avalglucosidase alfa-ngpt) |
| Drug | Nexviazyme |
| Manufacturer | Sanofi Genzyme |
| Route of Administration | Intravenous |
| Site of Care | Home or Healthcare Facility |
| Approved Indication | The treatment of patients 1 year of age and older with late-onset Pompe disease (lysosomal acid alpha-glucosidase [GAA] deficiency) |
| Disease | Pompe Disease |
| Therapeutic Area | Neurology, Genetics |
| Enrollment Form Link | Nexviazyme Enrollment Form Link |
| Phone Number | 800-240-9572 |
| Fax Number | 877-220-7581 |
| Product Website | nexviazyme.com |
| Patient Resources | Pompe Alliance, United Pompe Foundation |